These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29036293)

  • 1. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
    Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
    Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.
    Nathan V; Johansson PA; Palmer JM; Howlie M; Hamilton HR; Wadt K; Jönsson G; Brooks KM; Pritchard AL; Hayward NK
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):854-863. PubMed ID: 31233279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.
    Fidalgo F; Torrezan GT; Sá BCS; Barros BDF; Moredo LF; Valieris R; de Souza SJ; Duprat JP; Krepischi ACV; Carraro DM
    PLoS One; 2022; 17(1):e0262419. PubMed ID: 35085295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
    Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
    Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
    Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
    Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
    Rayner JE; Duffy DL; Smit DJ; Jagirdar K; Lee KJ; De'Ambrosis B; Smithers BM; McMeniman EK; McInerney-Leo AM; Schaider H; Stark MS; Soyer HP; Sturm RA
    PLoS One; 2020; 15(9):e0238529. PubMed ID: 32966289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.
    Hawkes JE; Cassidy PB; Manga P; Boissy RE; Goldgar D; Cannon-Albright L; Florell SR; Leachman SA
    J Dermatol Sci; 2013 Jan; 69(1):30-7. PubMed ID: 23103111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.
    Salgado C; Kwesi-Maliepaard EM; Jochemsen AG; Visser M; Harland M; van Leeuwen F; van Doorn R; Gruis N
    Melanoma Res; 2019 Dec; 29(6):582-589. PubMed ID: 31524790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
    Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
    Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
    Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
    Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
    Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
    BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
    Vergani E; Frigerio S; Dugo M; Devecchi A; Feltrin E; De Cecco L; Vallacchi V; Cossa M; Di Guardo L; Manoukian S; Peissel B; Ferrari A; Gallino G; Maurichi A; Rivoltini L; Sensi M; Rodolfo M
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
    J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
    Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
    Artomov M; Stratigos AJ; Kim I; Kumar R; Lauss M; Reddy BY; Miao B; Daniela Robles-Espinoza C; Sankar A; Njauw CN; Shannon K; Gragoudas ES; Marie Lane A; Iyer V; Newton-Bishop JA; Timothy Bishop D; Holland EA; Mann GJ; Singh T; Daly MJ; Tsao H
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29522175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
    Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
    J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Pfeiffer RM; Wheeler W; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Int J Cancer; 2009 Dec; 125(12):2912-7. PubMed ID: 19626699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.